# Risk: __Spread of SARS-COV-2__ (PBN__Risk_1728)

## Property: has_RiskISO_Impact

* [Health and care](../RiskISO/PBN__RiskISO_Purpose_0)

## Property: has_RiskTechnology

* [contact tracing apps](../Technology/PBN__Technology_11)
* [remote healthcare technologies](../Technology/PBN__Technology_1099)

## Property: has_RiskSubject

* [general population](../Stakeholder/PBN__Stakeholder_9)
* [healthcare workers](../Stakeholder/PBN__Stakeholder_68)
* [close contacts](../Stakeholder/PBN__Stakeholder_974)

## Property: has_RiskType

* [health](../RiskType/PBN__RiskType_4)

## Property: has_RiskISO_Purpose

* [Health and care](../RiskISO/PBN__RiskISO_Impact_3)

## Property: has_RiskOwner

* [government](../Stakeholder/PBN__Stakeholder_73)
* [healthcare institutions](../Stakeholder/PBN__Stakeholder_269)

## Property: has_RiskMitigation

* [Social distancing, wearing masks, hand hygiene](../RiskMitigation/PBN__RiskMitigation_2293)

## Property: has_RiskName

Rapid transmission, high mortality rate

## Property: has_RiskDescription

Transmission through droplets and contact

## Property: has_RiskSource

* [mecenas_effects_2020](../Article/PBN__Article_228)

## Property: has_RiskGBN

* [Yes](../RiskGBN/PBN__RiskGBN_1)

## Property: has_RiskHealth

* [physical](../RiskHealth/PBN__RiskHealth_0)

